From research tools to diagnostics to therapeutics, the local convergence of biology, genomics, immunology, and oncology with engineering, software, cloud computing and machine learning have created some of the industry’s most compelling companies. If your company, or one you advise, might be the next one, join us on March 23rd. You’ll hear from corporate venture leaders from J-LABS, Takeda Ventures, and Danaher about who and how they invest. Register here.